Prograf 0.5 mg Norsko - norština - Statens legemiddelverk

prograf 0.5 mg

orifarm as - takrolimus - kapsel, hard - 0.5 mg

Prograf 0.5 mg Norsko - norština - Statens legemiddelverk

prograf 0.5 mg

orifarm as - takrolimus - kapsel, hard - 0.5 mg

Prograf 0.5 mg Norsko - norština - Statens legemiddelverk

prograf 0.5 mg

orifarm as - takrolimus - kapsel, hard - 0.5 mg

Tacni 1 mg Norsko - norština - Statens legemiddelverk

tacni 1 mg

teva sweden ab - takrolimus - kapsel, hard - 1 mg

Tacni 0.5 mg Norsko - norština - Statens legemiddelverk

tacni 0.5 mg

teva sweden ab - takrolimus - kapsel, hard - 0.5 mg

Takrozem 0.1 % Norsko - norština - Statens legemiddelverk

takrozem 0.1 %

pierre fabre dermatologie - takrolimus - salve - 0.1 %

Promixin 1 mill IE Norsko - norština - Statens legemiddelverk

promixin 1 mill ie

orifarm as - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

Promixin 1 mill IE Norsko - norština - Statens legemiddelverk

promixin 1 mill ie

orifarm as - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

Promixin 1 mill IE Norsko - norština - Statens legemiddelverk

promixin 1 mill ie

2care4 - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

Omvoh Evropská unie - norština - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolitt, ulcerativ - immunsuppressive - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.